Lessons from the COVID-19 pandemic

LOCHMAN, Ivo; Vojtěch THON a Petr ŠÍMA. Lessons from the COVID-19 pandemic. Epidemiologie, Mikrobiologie, Imunologie. Praha: ČLS JEP, 2024, roč. 73, č. 1, s. 51-58. ISSN 1210-7913. Dostupné z: https://doi.org/10.61568/emi/11-6254/20240123/136242.

Základní údaje

Originální název

Lessons from the COVID-19 pandemic

Název česky

Poučení z pandemie covidu-19

Název anglicky

Lessons from the COVID-19 pandemic

Autoři

LOCHMAN, Ivo; Vojtěch THON a Petr ŠÍMA

Vydání

Epidemiologie, Mikrobiologie, Imunologie, Praha, ČLS JEP, 2024, 1210-7913

---

Další údaje

Jazyk

čeština

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 0.500

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14310/24:00137702

Organizační jednotka

Přírodovědecká fakulta

DOI

https://doi.org/10.61568/emi/11-6254/20240123/136242

UT WoS

001218688500001

EID Scopus

2-s2.0-85192037292

Klíčová slova česky

SARS-CoV-2; COVID-19; včasná léčba; aktuální stav

Klíčová slova anglicky

SARS-CoV-2; COVID-19; current status; timely treatment

Štítky

143180, rivok

Příznaky

Mezinárodní význam, Recenzováno

---

Anotace

V originále

The numbers of diagnosed and reported cases of infection with the SARS-CoV-2 virus causing the disease COVID-19, which grew into a global pandemic, have remained consistently low in all countries, including the Czech Republic, since May 2023, when the World Health Organization declared an end to the pandemic. However, it must be said that the measures implemented to control this infection did not meet all expectations. Although new mutations of the virus that can potentially cause disease, continue to emerge, it appears that most people have gradually learned to coexist with them. However, due to some unique properties of the SARS-CoV-2 virus and its variants, there will still be predisposed individuals who will develop illness and need hospitalization along with effective treatment to be supported and monitored by adequate laboratory tests. This article is a commentary on this issue and deals primarily with the diagnosis and care of early-phase COVID-19 patients.

Anglicky

The numbers of diagnosed and reported cases of infection with the SARS-CoV-2 virus causing the disease COVID-19, which grew into a global pandemic, have remained consistently low in all countries, including the Czech Republic, since May 2023, when the World Health Organization declared an end to the pandemic. However, it must be said that the measures implemented to control this infection did not meet all expectations. Although new mutations of the virus that can potentially cause disease, continue to emerge, it appears that most people have gradually learned to coexist with them. However, due to some unique properties of the SARS-CoV-2 virus and its variants, there will still be predisposed individuals who will develop illness and need hospitalization along with effective treatment to be supported and monitored by adequate laboratory tests. This article is a commentary on this issue and deals primarily with the diagnosis and care of early-phase COVID-19 patients.